---
granola_id: 00900a21-284c-47ce-8f0c-4795c918c37b
title: "Virtue <> Solstice Check-in"
type: note
created: 2025-06-11T17:39:41.137Z
updated: 2025-06-11T17:59:27.378Z
attendees:
  - aris@solsticehealth.co
  - yiwen@solsticehealth.co
  - kp@virtuevc.com
---
### Business Development Progress

- Stemline
	- MSA received recently
	- Live demo scheduled with marketing team
	- Positive meeting at ASCO conference
- Fathom Pharmaceuticals
	- Discussing implementation for Vokensa (GERD drug)
	- Potential for multiple brands
	- Currently in diligence phase
	- Connected with Ipsen contact for reference
- Sanofi
	- Ongoing discussions
	- Recent call with content gen team
	- Showing warm interest in collaboration

### Commercial Strategy & Pricing

- Brand-level pricing:
	- Range: $100k - $430k per brand per year
	- Enterprise deals: $300k - $500k for mid-sized/small companies
	- Context: Agencies currently charge $30-40k just for email content
- Service Model:
	- Initially managing service delivery internally for first few customers
	- Planning managed service approach for biopharma clients
	- No content generation services for agencies
	- Focus exclusively on biopharma content generation

### Team & Growth Plans

- Near-term hiring plans:
	- Head of Sales planned for October/November
	- Currently have two engineering interns
	- Likely to extend full-time offer to one intern
	- Additional engineering support needed (AI and potentially frontend)
	- Runway remains at approximately 30 months

Next Steps:

- Execute demo for Stemline
- Focus on closing initial biopharma contracts
- Evaluate agency relationships after securing initial pharma clients
- Begin search for Head of Sales
- Continue developing clear articulation of product value proposition vs traditional agency model

Chat with meeting transcript: https://notes.granola.ai/d/00900a21-284c-47ce-8f0c-4795c918c37b
